Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Modified poxviruses, including modified smallpox virus vaccine based on recombinant drug-sensitive vaccinia virus, and new selection methods

US Patent 8753648 · Granted Jun 17, 2014

Estimated economic value: $46,284,000

Assignee

Inventors

View full patent text on Google Patents →